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A B S T R A C T
The genome instability syndrome, ataxia-telangiectasia (A-T) is caused by null mutations in the ATM gene, that
lead to complete loss or inactivation of the gene’s product, the ATM protein kinase. ATM is the primary mobilizer
of the cellular response to DNA double-strand breaks (DSBs) – a broad signaling network in which many
components are ATM targets. The major clinical feature of A-T is cerebellar atrophy, characterized by relentless
loss of Purkinje and granule cells. In Atm-knockout (Atm-KO) mice, complete loss of Atm leads to a very mild
neurological phenotype, suggesting that Atm loss is not suﬃcient to markedly abrogate cerebellar structure and
function in this organism. Expression of inactive (“kinase-dead”) Atm (AtmKD) in mice leads to embryonic
lethality, raising the question of whether conditional expression of AtmKD in the murine nervous system would
lead to a more pronounced neurological phenotype than Atm loss. We generated two mouse strains in which
AtmKD was conditionally expressed as the sole Atm species: one in the CNS and one speciﬁcally in Purkinje cells.
Focusing our analysis on Purkinje cells, the dynamics of DSB readouts indicated that DSB repair was delayed
longer in the presence of AtmKD compared to Atm loss. However, both strains exhibited normal life span and
displayed no gross cerebellar histological abnormalities or signiﬁcant neurological phenotype. We conclude that
the presence of AtmKD is indeed more harmful to DSB repair than Atm loss, but the murine central nervous
system can reasonably tolerate the extent of this DSB repair impairment. Greater pressure needs to be exerted on
genome stability to obtain a mouse model that recapitulates the severe A-T neurological phenotype.
1. Introduction
The DNA damage response (DDR) is a main axis of genome stability
[1,2]. Severe DDR defects lead to genome instability syndromes, which
usually combine tissue degeneration, cancer predisposition, segmental
premature aging, and sensitivity to DNA damaging agents [3–7]. The
corresponding mouse models are important for understanding the link
between impaired DDR and the resultant phenotypes [8,1–10].
A prototype genome instability disorder is ataxia-telangiectasia (A-
T), a highly pleiotropic, autosomal recessive human disorder [11]
caused by mutations in the ATM (A-T, mutated) gene [12,13], which
encodes the ATM protein [14,15]. ATM is a homeostatic protein kinase
with many physiological functions [15,16–22]. A widely documented
one is its role as the chief mobilizer of the cellular response to DNA
double-strand breaks (DSBs), a complex, tightly regulated signaling
network that modulates numerous branches of cellular physiology in
response to DSB induction [2,15,23,24]. ATM activates and regulates
this network by phosphorylating a multitude of substrates in its various
branches [15,17,18,25,26]. ATM belongs to a family of PI-3 kinase-like
protein kinases (PIKKs), which includes, among others, the catalytic
subunit of the DNA-dependent protein kinase (DNA-PKcs) and ATR,
both of which are also involved in responding to genotoxic and other
stresses [27].
Most A-T mutations are null alleles that truncate the ATM protein.
Since truncated ATM is usually unstable, most A-T patients are typically
devoid of ATM [11,28]. The prominent symptom is progressive cere-
bellar ataxia that develops into severe motor dysfunction [11,29]. The
main underlying pathology is progressive cerebellar degeneration that
involves primarily Purkinje cells (PCs) and granule neurons. Peripheral
neuropathy may develop during the second decade of life. Oculocuta-
neous telangiectasia (dilated blood vessels) appear variably in the eyes
and facial skin. Marked immunodeﬁciency is manifested by reduction
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of various immunoglobulin isotypes, and diminished B and T lympho-
cyte counts. Lung infections often result from food aspiration combined
with the immunodeﬁciency. Another hallmark is gonadal and thymic
dysgenesis. Cancer predisposition is manifested as increased tendency
to develop lymphoreticular malignancies, and various carcinomas ap-
pear in older patients. Growth retardation and occasional endocrine
abnormalities are also seen, among them insulin-resistant diabetes. An
important, emerging aspect of A-T is premature aging [17],'evidenced
in part by the markedly accelerated senescence found in primary ﬁ-
broblasts derived from A-T patients [30]. Major laboratory ﬁndings are
elevated serum levels of alpha-fetoprotein and carcinoembryonic an-
tigen. A-T patients show a striking sensitivity to the cytotoxic eﬀect of
ionizing radiation (IR), and cultured A-T cells exhibit marked chro-
mosomal instability, sensitivity to IR and radiomimetic chemicals, and
reduced telomere length. IR sensitivity results from a profound defect in
initiating the ATM-dependent response to DSBs.
Many A-T symptoms can be attributed to the abrogation of the
cellular response to DSBs, both physiological ones and those induced by
endogenous reactive oxygen species. However, the cause of the most
devastating symptom – the progressive cerebellar atrophy – is still being
debated, in view of the many physiological functions of ATM in addi-
tion to its role in the DSB response [15–17,19–22,31–50]. An important
research tool in the attempts to understand this component of the A-T
phenotype is mouse models of A-T.
Most mouse models of A-T are based on truncating or frameshift
mutations in the murine Atm gene, similar to the null ATM mutations
that cause A-T in humans. Atm-deﬁcient mice were found to re-
capitulate major A-T symptoms, including the profound cancer pre-
disposition, acute radiation sensitivity and sterility, but were largely
spared the progressive cerebellar atrophy [51–54]. Several studies
noted, however, morphological and functional abnormalities in the
cerebellar cortex of Atm-deﬁcient mice, such as ectopic and abnormally
diﬀerentiated Purkinje cells [54], decreased duration of calcium cur-
rents and ﬁring in these cells [55], and degenerative changes in several
types of neurons, identiﬁed using electron microscopy [56]. Further
abnormalities were observed in tissue organization and various phy-
siological and molecular circuits of the murine Atm-deﬁcient nervous
system [39,51–70]. It appears, therefore, that Atm loss in the mouse can
cause physiological damage in various tissues, similar to what is seen in
A-T patients, but unlike the human cerebellum, the murine cerebellum
can largely tolerate Atm loss and maintain its neuromotor functions.
Furthermore, daily monitoring of Atm-deﬁcient mice in our colonies
turned up no behavioral abnormalities in animals up to 2 years of age.
One possible approach to obtaining a mouse model of A-T that will
exhibit cerebellar atrophy is to induce Atm mutations in this organism
that will produce a harsher eﬀect than that caused by the null alleles
that eliminate the Atm protein. Such are mutations that produce cata-
lytically inactive (‘kinase-dead’) Atm.
Yamamoto et al. [71] and Daniel et al. [72] showed that expression
of physiological levels of kinase-dead in mice Atm leads to early em-
bryonic lethality. Furthermore, cultured cells expressing inactive Atm
exhibited greater genome instability compared to Atm-deﬁcient cells
[71,72]. Detailed mechanistic explanations for this observation are
lacking, but it is assumed that the presence of inactive Atm interferes
with the cellular response to genotoxic stress, such as the cleavage of
trapped protein adducts in replicating cells [73], and perhaps other
ATM-dependent pathways more than does the absence of Atm [74]. We
asked therefore whether conditional expression of kinase-dead Atm in
the nervous system of the mouse will exert a more profound cerebellar
eﬀect than Atm loss.
2. Materials and methods
2.1. Mouse strains
Animals were held in a speciﬁc pathogen-free facility. All
experimental procedures complied with the standards as deﬁned by the
National Institutes of Health Guide for the Care and Use of Laboratory
Animals and approved by the Tel Aviv University Institutional Animal
Care and Use Committee.
The study was carried out using mice with a mixed C57BL/129 Sv
background. The following Atm alleles were used: an Atm-knockout
allele (Atm−) [51] (B6.129S6-Atmtm1Awb/J in the Jackson Labs Re-
pository); a ‘ﬂoxed’ Atm allele (Atmﬂ) containing loxP sites ﬂanking
exons 57–58 of the gene [75,76] (strain 129-Atmtm2.1Fwa/J in Jackson
Labs; and a kinase-dead Atm allele (AtmKD), which produces an Atm
protein with two inactivating amino acid substitutions (D2880 A/
N2885 K) in its catalytic domain [71]. Cre recombinase expressed from
a transgene driven by the Nestin promoter (strain B6.Cg-Tg(Nes-cre)
1Kln/J in the JAX Repository) was used to inactivate ﬂoxed alleles in
the central nervous systems [77]. The L7 (Pcp2) promoter was used to
express Cre in PCs [78] (JAX strain Tg(Pcp2-cre)1Amc/J).
2.2. Antibodies
The following antibodies were used: polyclonal goat anti-Calbindin
D28 K (Santa Cruz Biotechnology Inc., Santa Cruz, CA), monoclonal
mouse anti-Neuronal Nuclei (NeuN) (Millipore, Billerica, MA), poly-
clonal rabbit anti GABA(A) receptor alpha 6 subunit receptor
(Millipore, Temecula, CA), monoclonal mouse anti-pS139-H2AX
(Merck Millipore, Darmstadt, Germany), polyclonal rabbit anti-53BP1
(Novus Biologicals, Littleton CO), monoclonal rabbit anti-ATM D2E2
(Cell Signaling, Danvers, MA), polyclonal rabbit anti-pS824- KAP-1
(Bethyl Laboratories, Montgomery, TX), monoclonal mouse anti-KAP-1
(BD Transduction Laboratories, San Jose, CA), monoclonal mouse anti-
HSC70 (Santa Cruz Biotechnology Inc., Santa Cruz, CA).
2.3. Inhibitors
DNA-PK inhibitor: NU7441 (Tocris Bioscience, Bristol, UK). ATR
inhibitor: AZ20 (Tocris).
2.4. X-irradiation
Mice underwent total body irradiation using an X-irradiator
(160 H F, Philips, Germany) at a dose rate of 1 Gy/min. Cultures were
irradiated using an X-irradiator (Faxitron, Tucson, AZ) at a dose rate of
0.5 Gy/min.
2.5. Immunoblotting of mouse tissues
Irradiated mice were sacriﬁced 30min after irradiation and organs
were immediately harvested and snap-frozen in liquid nitrogen. Protein
extraction and immunoblotting were performed as previously described
[79,80].
2.6. Histological analysis
Mice were anesthetized with 1% Ketamine and 0.1% Xylazine so-
lution (1ml per 10 g of body weight) and sacriﬁced by PBS perfusion.
Cerebellar tissues were ﬁxed in 4% paraformaldehyde and dehydrated
in graded ethanol series using the Leica TP1020 Tissue Processor. The
tissues were cut into 10 μm parasagittal sections, deparaﬃnized in two
5min incubations in xylene and rehydrated in a graded series of
ethanol. The sections were then stained using hematoxylin and 1%
eosin solution (Kaltec, Padova, Italy). For immunostaining, the sections
were treated with antigen unmasking solutions (Vector Laboratories,
Burlingame, CA), washed with PBS, and blocked with PBSTg (0.2%
Tween, 0.2% gelatin in PBS). The tissue sections were then incubated
with the primary antibody overnight, washed with PBS and PBSTg and
incubated with the secondary antibody in PBS for 2 h. The sections were
then washed and stained with 0.1 mg/ml 4,6- diamidino-2-
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phenylindole (DAPI), and mounted with aqueous mounting medium
containing anti-fading agents (Biomeda Corp, Foster City, CA).
Immunoﬂuorescent images were captured using a Leica TCS SP2 con-
focal microscope (Leica Microsystems GmbH, Germany).
2.7. Cerebellar organotypic cultures
Cerebellar organotypic cultures were established and stained as
previously described [81,82]. Cultures were X-irradiated 12 days after
their establishment.
2.8. Behavioral analysis
Initial testing for possible behavioral changes reﬂecting cerebellar
defects was based on the scoring scheme described by Guyenet et al.
[83]. Mice were tested once every 1–3 months from 1 to 24 months of
age. Tests included hind limb clasping, ledge test, gait and appearance
of kyphosis [83]. Animals were also examined at 12 and 20 month
using the computerized CatWalk gait analysis system (Noldus, Wagen-
ingen, Netherlands, which recorded and subsequently analyzed the
animals’ footprints as they went along a glass runway 3 times. Mice
were also tested for general locomotor activity and willingness to ex-
plore using an open ﬁeld test performed in a 50 X 50 cm arena for
20min. Their motion was recorded using a GigE color 1/2″ Basler
acA1300-60gc camera (Basler, Ahrensburg, Germany) and analyzed
using EthoVision XT 11.5 software (Noldus). The CatWalk and Open
Field tests were carried out in the Myers Neuro-Behavioral Core Facility
of Tel Aviv University.
3. Results
3.1. Generation of mice expressing no Atm or kinase-dead Atm in the CNS
or in PCs only
Mice in which Atm is conditionally ablated in the CNS (Atm-Δ-CNS)
or speciﬁcally in PCs (Atm-Δ-PC) were obtained by combining an Atm−/
ﬂ genotype with expression of Nes-Cre or Pcp2-Cre, respectively. (The
use of a ﬂoxed Atm allele against a null allele was intended to increase
the chance of eliminating the Atm protein in the target cells by reducing
the occurrence of excision of one out of two ﬂoxed alleles). Lifespan and
cage behavior of both the Atm-Δ-CNS and Atm-Δ-PC animals were
normal. Mice expressing AtmKD in the CNS or speciﬁcally in PCs (Atm-
KD-CNS and Atm-KD-PC, respectively) were obtained by combining the
Nes-Cre or Pcp2-Cre transgenes with an Atmﬂ/KD genotype (Fig. 1). In
these animals, the Atmﬂ allele was expected to be inactivated by the Cre
recombinase, leaving AtmKD as the only viable Atm allele in Cre-
expressing cell types. Of note, the Atmﬂ/KD genotype itself (which is
common to all body cells) does not cause any discernible phenotype
[71]. Both the Atm-KD-CNS and Atm-KD-PC mice were viable and
completed a normal lifespan. Notably, the body weight of the mice
expressing the Nestin-Cre was reduced compered to non-Nestin-Cre
expressing animals (Supplementary Fig. 1). This was previously re-
ported and attributed to metabolic eﬀects of nestin promoter-driven
expression of the Cre recombinase [84].
3.2. Atm level and activity readout in tissues of mice with diﬀerent Atm
genotypes
Immunoblotting analysis of tissue extracts from the Atm-Δ-CNS mice
indicated that Atm protein level was below detection in the cerebrum
and cerebellum of these animals (Fig. 2a). As expected, the Atm signal
obtained from CNS tissues of the Atm-KD-CNS animals was lower than
that of WT tissues (Fig. 2a), since it represented only one allele that
expresses the mutant protein. We also examined a well-documented
readout of ATM activity after DSB induction: the robust phosphoryla-
tion of its substrate, KAP-1 on Ser824, which is detected using a highly
speciﬁc anti-phospho antibody [85]. Indeed, 30min following treat-
ment of the animals with 10 Gy of IR, Kap-1 phosphorylation in the
Atm-Δ-CNS and Atm-KD-CNS animals was considerably reduced in the
CNS but not in the spleen, which served as the control tissue (Fig. 2a).
This result indicated that AtmKD was indeed catalytically inactive in the
Atm-KD-CNS animals. The residual phosphorylation of Kap-1 that is
occasionally detected in the absence of Atm activity in the brain
(Fig. 2a) is attributed primarily to DNA-PK [76] (and our unpublished
data). Similar results were obtained in cerebellar organotypic (slice)
cultures, which we routinely use to analyze the cerebellar DDR [81,82].
These cultures maintain the organization of the cerebellar tissue for
several weeks in culture and are amenable to treatment with DNA da-
maging agents [65,81,82]. The cultures were irradiated, and phos-
phorylations of histone H2ax and Kap-1 were detected using im-
munostaining. Both phosphorylations were profoundly down-regulated
in Atm-Δ-CNS and Atm-KD-CNS cultures (Fig. 2b). Notably, this result
suggests that in this tissue Atm has a major role in H2ax and Kap1
phosphorylation in response to DSB induction. Importantly, a small,
distinct group of cells exhibited vigorous Kap-1 phosphorylation in both
mutant genotypes (Fig. 2b), presumably representing cells in which the
Nestin promoter had not been activated during development or cells in
which the ﬂoxed Atm allele had escaped Cre-mediated excision.
We used inhibitors against DNA-PK and ATR to assess the share of
each of the three PIKKs in these phosphorylations in the murine cere-
bellum. Inhibition of Dna-pk or Atr in Atm-proﬁcient, Atmf/f cells re-
duced the two phosphorylations considerably (Fig. 2b), pointing to the
Fig. 1. Generation of mice expressing AtmKD speciﬁcally
in the central nervous system or in PCs. Breeding scheme
using the Cre-lox system to generate mice expressing kinase-
dead Atm in the CNS or speciﬁcally in PCs. The animals are
compound heterozygotes at the Atm locus: one allele is ﬂoxed
and the other expresses kinase-dead protein (AtmKD). The
ﬂoxed allele is inactivated by the Cre recombinase, which is
expressed in the CNS when driven by the Nestin promoter, or
in PCs under the control of the Pcp2 promoter.
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importance of concerted action of these kinases in these damage-in-
duced phosphorylations in this organ.
Fig. 2c presents similar analysis of cerebellar organotypic cultures
derived from Atm-Δ-PC and Atm-KD-PC mice demonstrating the lack of
Atm activity speciﬁcally in PCs of both genotypes.
Fig. 2. AtmKD expression in the CNS and
functional consequences. a. Western
blotting analysis of cerebellum, cerebrum
and spleen with diﬀerent genotypes after
whole-body irradiation with 10 Gy of IR.
Phosphorylation of the Atm substrate,
Kap-1, 30min after irradiation was used as
a readout of Atm activity in response to
DNA damage. b. Immunostaining of
phosphorylated Kap-1 in organotypic cer-
ebellar cultures established from P12
mice. Cultures were pretreated with
DMSO or 5 μM NU7441 – a DNA-PK in-
hibitor (DNA-PKi), or 0.5 μM AZ20 – an
ATR inhibitor (ATRi), and irradiated with
10 Gy of IR. The merged images include
Calbindin D28k staining (green), which
labels PCs and DAPI staining (blue), which
labels cell nuclei. c. Similar analysis as in
(b) in cerebellar organotypic cultures de-
rived from WT, Atm-Δ-PC and Atm-KD-PC
mice. Note the lack of Kap-1 phosphor-
ylation in PCs only, in both genotypes. PCs
are marked by Calbindin D28k staining
(green).
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3.3. Expression of catalytically inactive Atm in the CNS impairs DSB repair
in PCs, more than Atm absence
In order to follow DSB repair in PCs with the various Atm genotypes,
we used cerebellar organotypic cultures treated with IR. We monitored
in PCs the dynamics of two immunoﬂuorescent DSB readouts: nuclear
foci of phosphorylated histone H2ax (γH2ax) and the DDR protein,
53bp1 [86]. In the early time points after irradiation, the response in
Atm-deﬁcient cells was reduced compared to Atm-proﬁcient cells, but
later on, the decline in foci number over time, which is considered to
represent DSB repair, was delayed in PCs from Atm-Δ-CNS and Atm-KD-
CNS animals compared to the Atmﬂ/ﬂ genotype (Fig. 3c, d). Importantly,
the delay in DSB repair was greater in PCs in Atm-KD-CNS cultures than
in those of Atm-Δ-CNS mice (Fig. 3c, d). This result suggests that the
presence of kinase-dead Atm in the CNS exerts a more pronounced ef-
fect on DSB repair than Atm absence. This result is in accord with
previous ﬁndings showing greater genome instability in murine em-
bryonic stem cells and lymphocytes expressing kinase-dead Atm com-
pared to those lacking Atm altogether [71,72]. Interestingly, however,
when Atm loss or replacement by a kinase-dead protein was conﬁned to
PCs, the increased impact on DSB repair of inactive Atm compared to
Atm loss was not observed (Fig. 3e, f). It should be stressed in this
regard that, in the Atm-KD-PC expression of kinase-dead Atm was
conﬁned to PCs while the surrounding cells contained normal levels of
WT Atm, as evidenced by the Atm activity assay (Fig. 2c).
3.4. Conditional expression of inactive atm in the CNS or just in PCs does
not lead to a signiﬁcant neurological phenotype
The animals expressing kinase-dead Atm in the CNS or in PCs were
tested every 1–3 months from 1 to 24 months using the Gait Test and
Ledge Test that measure coordination of movements, and the Hind
Limb Clasping Test, that can highlights severe cerebellar abnormalities.
Special attention was paid to the appearance of kyphosis, which may be
caused by the loss of muscle tone in the spinal muscles secondary to
neurodegeneration [83]. No abnormalities were observed in these
parameters in the two mutant genotypes (data not shown) during the 24
months. When the mice were evaluated at 20 months using the Open
Field and CatWalk systems Atm-KD-CNS, but not Atm-KD-PC mice de-
monstrated changes in their footprints suggesting alterations in step-
ping pattern and coordination (Fig. 4e). However, collectively all other
parameters did not detect behavioral pattern suggesting cerebellar
dysfunction (Fig. 4). Similar to the normal neurological phenotype
observed in mice expressing kinase-dead Atm in the CNS, Atm-Δ-CNS
mice expressing no Atm protein in the CNS also displayed no signiﬁcant
phenotype. Some behavioral changes were observed in the Atm-Δ-CNS
and Nestin-Cre-expressing mice which might due to the Cre expression
in the tissue (Supplementary Fig. 2). We concluded that conditional
expression of AtmKD in the CNS or PCs did not lead to changes in be-
havior indicative of motor deﬁcits.
The cerebellar structure and organization of the animal were ex-
amined every 3 months from 3 weeks to 24 months using hematoxylin-
eosin staining and immunohistochemical staining of cell type markers.
No gross organizational abnormalities in the cerebella of the Atm-KD-
CNS and Atm-KD-PC animals were observed during this period (Fig. 5).
4. Discussion and conclusions
The conditional ablation of the Atm gene in the Atm-Δ-CNS mouse
allows circumventing the extreme cancer predisposition of the Atm−/−
Fig. 3. AtmKD in PCs impairs DSB repair more than Atm absence, in Atm-KD-CNS but not in Atm-KD-PC mice. Organotypic cultures were produced from P12
mice and grown for 12 days. a,b. Representative images of γH2ax and 53bp1 foci in Atmf/f cultures, 30min after irradiation with 2 Gy of IR. c,d. Quantiﬁcation of
γH2ax nuclear foci (c) or 53bp1 foci (d) in PCs from Atm-KD-CNS mice. e,f. Similar data obtained from Atm-KD-PC mice. The results represent the average counts in
90 PCs at each time point in 3 separate experiments. Standard error is as shown. Two-tail t-test was used to determine statistical signiﬁcance between pairs of mice
with diﬀerent genotypes. * p < 0.05, ** p < 0.005, *** p < 0.0005. Non-underlines asterisks refer to the signiﬁcance of the diﬀerences between the Atmﬂ/ﬂ and
Atm-KO-CNS or Atm-KD-CNS genotypes; underlined asterisks refer to the signiﬁcance of the diﬀerences between Atm-KO-CNS and Atm-KD-CNS.
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genotype leading to Atm loss in all body tissues, and enables following
the animal’s neuromotor performance throughout a full life span.
Expression of AtmKD in the CNS was expected to take the pressure on
genome stability one step further. Our and previous [71,72] results
suggest that conditional expression of AtmKD in various tissues does not
lead to the embryonic lethality caused by whole body expression of
inactive Atm. The embryonic lethality may result from interference
with a critical developmental step. However, if that step is successfully
executed, the DDR abrogation caused by AtmKD expressed conditionally
in a speciﬁc tissue is not suﬃcient to undermine the tissue’s integrity or
function. Thus, intensifying the DSB repair defect associated with Atm
loss by expressing AtmKD in the murine CNS was not suﬃcient to aﬀect
the structure and function of the corresponding cell types and the tissue
at large. The practical conclusion from these results is that, in order to
obtain a mouse model that satisfactorily recapitulates the A–T neuro-
logical phenotype, further abrogation of the DNA damage response or
exertion of higher genotoxic pressure on the murine cerebellum might
be required.
It is still interesting, why AtmKD exerts a more pronounced eﬀect on
DSB repair compared to Atm loss. A portion of nuclear ATM is recruited
to DSB sites [87] and is thus part of the nuclear foci that are meticu-
lously formed around these sites [88]. Many of the ATM-mediated
phosphorylations occur within these protein structures, whose ﬁne or-
ganization is critical for the delicate balance among DSB repair path-
ways and subsequently - timely DSB repair [89]. Importantly, AtmKD is
recruited to DSB sites same as active Atm [71,72]. The experimental
results suggest that the presence of inactive Atm within the complex
multiprotein structures that are constructed around DSBs abrogates
their organization and subsequently DSB repair, more that ATM ab-
sence.
The comparison between Atm-KD-PC and Atm-KD-CNS animals
highlighted a diﬀerence in the eﬀect of AtmKD on DSB repair in PCs
surrounded by AtmKD-expressing cells or PCs with AtmKD surrounded
by WT cells. This result may point to the importance of the surrounding
cells in determining the functional outcome of PCs’ own Atm genotype.
Support for this concept comes from a recent study with mixed cell
cultures, in which the functionality of Atm-deﬁcient murine granule
cells depended on the Atm genotype of astrocytes that interacted with
them [90]. Thus, conditional expression of Atm genotypes in a speciﬁc
cell type may yield diﬀerent physiological results depending on the
genotype of surrounding cells. Our results therefore surface certain
limitations of the conclusions that can be drawn when the Cre-lox
technology is used for tissue-speciﬁc gene manipulation. An over-
arching conclusion concerning A-T is emerging from studies based on
CNS-speciﬁc ablation of the Atm gene in mice: the cerebellar atrophy in
A-T may be inﬂuenced not only by Atm loss in speciﬁc cerebellar cell
types, but also by lack of Atm in other tissues that neighbor or connect
with the cerebellum.
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